ABOUT THIS PODCAST
This episode dives into the ASHP Guidelines on the Evaluation of Off-Label Medication Use in the Inpatient Setting. Off-label prescribing is a common yet complex practice in hospitals, requiring careful oversight to ensure safety, efficacy, and cost-effectiveness. We’ll explore the pharmacist’s role in this process, the importance of institutional policies, and how Pharmacy and Therapeutics (P&T) Committees can support appropriate use. Whether you're a pharmacy leader, clinician, or health-system administrator, this conversation offers practical insights for navigating off-label use with confidence and clarity.
SPEAKERS
- Monica Mehta, PharmD, MPH
Director, Policy Planning, ASHP - Karin Durant, PharmD
Assistant Director, Medication Use Policy, University of Michigan Health - Maggie Segovia, PharmD
Formulary/Drug Policy Specialist, University Hospitals - Nisha Matthew, PharmD, MBA, BCPS, BE
Clinical Pharmacist, Florida Coast Medical Center - Julie Gwin, PharmD
Pharmacy Clinical Coordinator, Lankenau Medical Center
